US Stock MarketDetailed Quotes

KALV KalVista Pharmaceuticals

Watchlist
  • 12.500
  • +0.410+3.39%
Close Oct 18 16:00 ET
  • 13.120
  • +0.620+4.96%
Post 20:02 ET
540.19MMarket Cap-3501P/E (TTM)

KalVista Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

KalVista Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 1.691M--
--2025/Q2-- / 0.000--
--2025/Q10.000 / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 1.691M--
--2025/Q2-- / 0.000--
--2025/Q10.000 / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--

Unlock Free Earnings Estimates

KalVista Pharmaceuticals Earnings Reports

  • KalVista Pharmaceuticals | 10-Q: Q1 2025 Earnings Report

    Sep 5 16:18 ET

  • KalVista Pharmaceuticals | 10-K: FY2024 Annual Report

    Jul 11 16:15 ET

  • KalVista Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Mar 11 16:28 ET

  • KalVista Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Dec 7, 2023 16:07 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 11, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data